Sign in
4

Changes in Ownership

NRX Pharmaceuticals, Inc. Filed Acc 0001415889-23-013139

Director bought 35,000 shares at $0.32 ($11,197)

From the SEC's structured data for this filing

Trades in this filing

Gorovitz Aaron · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-08-30 Purchase : show line 1 in the form +35,000 $0.32 $11,197 105,000 I
Open-market purchases · 35,000 sh · avg $0.32 · $11,197
Loading xslF345X05/form4-09112023_010928.xml…